Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Symmetric and asymmetric dimethylarginine as risk markers of cardiovascular disease, all-cause mortality and deterioration in kidney function in persons with type 2 diabetes and microalbuminuria

Abstract Background To evaluate symmetric dimethylarginine (SDMA) and asymmetric dimethylarginine (ADMA) as risk markers of cardiovascular disease, all-cause mortality and deterioration in renal function in a well characterised type 2 diabetic population with microalbuminuria and without symptoms of...

Full description

Bibliographic Details
Main Authors: Emilie H. Zobel, Bernt Johan von Scholten, Henrik Reinhard, Frederik Persson, Tom Teerlink, Tine W. Hansen, Hans-Henrik Parving, Peter K. Jacobsen, Peter Rossing
Format: Article
Language:English
Published: BioMed Central 2017-07-01
Series:Cardiovascular Diabetology
Subjects:
Microalbuminuria
Type 2 diabetes
Cardiovascular disease
Macrovascular disease
Symmetric dimethylarginine
Asymmetric dimethylarginine
Online Access:http://link.springer.com/article/10.1186/s12933-017-0569-8

Internet

http://link.springer.com/article/10.1186/s12933-017-0569-8

Similar Items